Learn More
Gibco™ Human IL-17A Recombinant Protein
Description
Carrier-Free Reconstitution: We recommend that the vial be briefly centrifuged prior to opening to bring the contents to the bottom. Lyophilized human IL-17A should be reconstituted in sterile, distilled water to a concentration of 0.1-1.0 mg/mL. For maximal stability, a carrier protein, such as 0.1-1.0% BSA, may be included. The reconstituted protein should be apportioned into working aliquots and stored at ≤-20°C. Further dilutions should be made in low endotoxin medium or buffered solution with FBS or tissue culture grade BSA. Storage: For maximal stability, store this lyophilized preparation at ≤-20°C, preferably desiccated. For shipment and short term storage (up to 2 weeks), storage at 2°C to 8°C is sufficient. Reconstituted human IL-17A should be stored at ≤-20°C (not in a frost-free freezer). Keep freeze-thaw cycles to a minimum.
Specifications
Specifications
| Accession Number | Q16552 |
| For Use With (Application) | Bioactivity |
| Formulation | Protein with no preservative |
| Gene ID (Entrez) | 3605 |
| Molecular Weight (g/mol) | 15.5 kDa |
| Name | Human IL-17A |
| Purification Method | Purified |
| Quantity | 1 mg |
| Storage Requirements | -20°C |
| Regulatory Status | RUO |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.